Oliver Lagore Vanvalin Investment Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.3K | Buy |
+200
| New | +$22.3K | 0.01% | 329 |
|
|
2024
Q4 | $19.5K | Hold |
200
| – | – | 0.01% | 366 |
|
|
2024
Q3 | $23K | Hold |
200
| – | – | 0.01% | 332 |
|
|
2024
Q2 | $21.3K | Hold |
200
| – | – | 0.01% | 329 |
|
|
2024
Q1 | $19.3K | Sell |
200
-33
| -14% | -$3.19K | 0.01% | 340 |
|
|
2023
Q4 | $23.5K | Sell |
233
-45
| -16% | -$4.54K | 0.01% | 295 |
|
|
2023
Q3 | $28.3K | Buy |
278
+98
| +54% | +$9.98K | 0.01% | 305 |
|
|
2023
Q2 | $18.2K | Hold |
180
| – | – | 0.01% | 381 |
|
|
2023
Q1 | $16.6K | Hold |
180
| – | – | 0.01% | 307 |
|
|
2022
Q4 | $16.3K | Hold |
180
| – | – | 0.01% | 300 |
|
|
2022
Q3 | $14K | Hold |
180
| – | – | 0.01% | 291 |
|
|
2022
Q2 | $15K | Hold |
180
| – | – | 0.01% | 293 |
|
|
2022
Q1 | $16K | Buy |
+180
| New | +$16K | 0.01% | 282 |
|